Standard BioTools (LAB)
Standard BioTools (LAB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- LAB last traded at $0.61 on 2026-11-19, 7.67% for the session.
- Standard BioTools: market cap $242.28M, P/E 1.8, revenue $84.43M over the last four quarters.
- Over the past year LAB returned -52.05%, with a year-to-date return of -52.05%.